FAQs

If you are eligible for 2 (or more) different types of tickets due to your dual (or more) affiliations, then the most expensive ticket type applies. For example, if you qualify for a free ticket due to working for a research organization but also work for a Solution Provider / Technology Provider then you must purchase a Solution Provider / Technology Provider ticket. 

Registering (filling out the registration form) does not automatically qualify you for a ticket. After registering you will receive an email acknowledging your registration. Your registration will then be verified by one of the Front Line Genomics team, and you will receive an email letting you know if your registration has been successful or if your ticket has been cancelled (e.g. because you don't meet the eligibility criteria for the ticket you applied for). 

This process is in place for security reasons - to avoid people attending the Festival under a different identity.

No, sadly not. We are not anticipating releasing tickets for unemployed people this year. This policy will remain under review with changes possible for the 2027 Festival.

No. The Festival is taking place in-person ONLY. So, to participate in the Festival, and to receive access to on-demand session recordings after the Festival, you will need to travel to Boston and attend in-person. 

You must use your work/organization email address when registering for the Festival. We do not accept registrations using a personal email address. This is for security reasons.

A Festival ticket gives you access to the theatres for the agenda sessions, networking activities, the main exhibition floor and the drinks reception as well as a host of activities taking place during the Festival itself.

The Festival is free to attend for people working exclusively for a healthcare provider (such as a hospital or clinic), a research institution, a governmental body, a registered charity or a pharmaceutical company (with an existing drug pipeline). 

This ticket applies if you work for a company that sells technology or solutions to research institutions, hospitals or pharma companies. This ticket is also the correct option for companies that sell services or products to our sponsors and exhibitors. 

If you purchase the wrong type of ticket (for example, you purchase a student ticket when you should have purchased a Technology/Solution Provider ticket), your ticket will be cancelled, and a partial refund given (after credit card processing fees and a £10 admin fee have been applied). 

There are no tickets available for undergraduate or master’s students this year. PhD students are able to attend as normal.

To apply for a press pass please contact  info@frontlinegenomics.com Please note it is not possible to apply for a press pass during the Festival. Press passes must be applied for in advance. 

Following feedback from attendees and exhibitors, we've taken the difficult decision not to allow access to any recruitment consultants for the Festival in 2026. 

No, we will arrange this all for you. Your speaker pass will be sent to you by email shortly before the event takes place.

Front Line Genomics. We are a social business, set up after the death of our CEO’s father to a rare form of cancer. We are independently run, with no external stakeholders or investors. As such, we are free to emphasize social impact over profit and shareholder return. You can read more about our origins here  or at  www.frontlinegenomics.com.  

The first Festival took place in Boston in June 2015. In total, this is the 7th Festival we have run in Boston. Since the first Festival took place, we have welcomed over 50,000 people through the Festival doors - in both the UK and USA, 97% of whom have attended for free.

Yes. The London Festival of Genomics & Biodata has been running annually since 2026, allowing for two years when we ran the Festival online. The London Festival is currently the UK and Europe’s largest life sciences event by attendance, with over 8,000 registrants.

This is as a direct consequence of our social mission. Being a social business means we prioritise social impact over profit, which greatly influences our decision to issue free tickets for most attendees. We would make much more money selling tickets. But, in simple terms, the more people attend (because tickets are free), the more attendees improve patient outcomes through what they learn/discover at the Festival. Therefore, patients ultimately benefit.

We are able to subsidize free attendance and cover the cost of running the Festival because of the contributions of our sponsors and exhibitors. The more effective the Festival is in achieving their business objectives, the easier it is for us to keep attendance free for so many. So please go and explore what they have to offer!

This sometimes confuses people, because so much of what is covered I the event is not specifically genomics (although, thanks to the central dogma, it’s all related).

When the Festival was started in 2026, the principle focus was genomics and genomic data. Since then, like many genomics technology companies, we have branched out beyond genomics into other related areas, including transcriptomics, proteomics, single cell and spatial analysis, cancer diagnostics, multi-omics, omics-drive drug discovery and development, AI and biodata projects and infrastructure. Genomics is still (and will remain) a core component of the Festival, but the event has so much to offer for people whose principle focus is not genomics. The priority is patient impact - we cover topics that are able to impact patient outcomes.

One of the unique features of the Festival is all attendees (you must have attended in person) can access on-demand recordings for all Festival sessions (where we have speaker permission) across all 8 theatres, approximately two weeks after the Festival takes place. This means you do not have to worry – when onsite - about missing sessions in the seven theatres you are unable to attend.

All in-person attendees will be sent a link around two weeks after the Festival. Typically, fewer than 5% of speakers refuse permission for on-demand sharing.

Keeping the Festival free to attend, in the long run, is the priority. It’s important to the business model that supports free attendance of the Festival that we create a vibrant, dynamic, well-attended LIVE event. We want to ensure as many people attend the in-person Festival as possible, so that our sponsors and exhibitors (who ultimately pay for the event and subsidize free tickets) meet as many people as possible. This keeps this, and future Festivals, free to attend for more than 90% of our attendees. We have previously trialed hybrid events, at a smaller scale than the Festival, but most attendees watched remotely. Therefore, we chose not to adopt this hybrid approach for our Festivals.